Gene · 8554
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated bioinformatics and pharmacology reveal esculin's mechanism against pancreatic adenocarcinoma drug resistance. | Phytomedicine | 2026 | 41351980 | PubTator, text mining | PubMed |
| Research Progress on Genetic Factors of Poultry Egg Quality: A Review. | Animals (Basel) | 2025 | 41463936 | PubTator, text mining | PubMed |
| Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance. | Oncogenesis | 2025 | 41430042 | PubTator, text mining | PubMed |
| Six-methoxyflavone suppresses CircPIAS1 biogenesis via targeting PTBP1 and, in combination with IFN-γ, promotes ferroptosis in melanoma. | Front Pharmacol | 2025 | 41347180 | PubTator, text mining | PubMed |
| PIAS1/PIAS4-Mediated SUMOylation of TDP-43 Is Induced by Oxidative Stress. | bioRxiv | 2025 | 41292941 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals PIAS family gene dysregulation as a driver of head and neck squamous cell carcinoma (HNSC) progression and therapeutic vulnerability. | Discov Oncol | 2025 | 41261346 | PubTator, text mining | PubMed |
| Highly expressed TRIM32 promoted traumatic wound healing by mediating ubiquitination of PIAS1. | Mamm Genome | 2025 | 41125973 | PubTator, text mining | PubMed |
| Functional Characterization and Prognostic Value of PIAS Family Genes in Liver Hepatocellular Carcinoma. | Curr Cancer Drug Targets | 2025 | 41121482 | PubTator, text mining | PubMed |
| Chenodeoxycholic Acid Alleviates High-Fat Diet-Induced Lipid Deposition via FXR/SHP/PIAS1/SUMO1-Dependent SREBP1K264 SUMOylation in Yellow Catfish. | J Nutr | 2025 | 40998123 | PubTator, text mining | PubMed |
| EBNA1 SUMOylation by PIAS1 Suppresses EBV Lytic Replication and Enhances Episome Maintenance. | bioRxiv | 2025 | 40950008 | PubTator, text mining | PubMed |
| PIAS1 Shapes a Tumor-Suppressive Microenvironment by Suppressing Immune Evasion in Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2025 | 40941002 | PubTator, text mining | PubMed |
| Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. | BMC Neurol | 2025 | 40890629 | PubTator, text mining | PubMed |
| Targeted RNA sequencing identified gene expression profiles linked to severe necrosis and mortality in preterm infants with surgical necrotizing enterocolitis. | Res Sq | 2025 | 40766230 | PubTator, text mining | PubMed |
| Targeting the interaction between long noncoding RNA XR_001779380 and Prdm1 to enhance IFN-γ immunity in murine neonatal intestinal epithelial cells. | mBio | 2025 | 40497734 | PubTator, text mining | PubMed |
| Tumor Small Extracellular Vesicle-Transmitted LncRNA CATED Promotes Platinum-Resistance in High-Grade Serous Ovarian Cancer. | Adv Sci (Weinh) | 2025 | 40492382 | PubTator, text mining | PubMed |
| Genetic Determinants of Colonic Diverticulosis-A Systematic Review. | Genes (Basel) | 2025 | 40428403 | PubTator, text mining | PubMed |
| JAK-STAT Signaling in Autoimmunity and Cancer. | Immunotargets Ther | 2025 | 40376194 | PubTator, text mining | PubMed |
| Computational drug discovery of phytochemical alkaloids targeting the NACHT/PYD domain in the NLRP3 inflammasome. | Sci Rep | 2025 | 40368915 | PubTator, text mining | PubMed |
| Interaction networks of SIM-binding groove mutants reveal alternate modes of SUMO binding and profound impact on SUMO conjugation. | Sci Adv | 2025 | 40367183 | PubTator, text mining | PubMed |
| SPOP mutations increase PARP inhibitor sensitivity via CK2/PIAS1/SPOP axis in prostate cancer. | JCI Insight | 2025 | 40260915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8554/papers?page=2